- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 264-278 of
466 results
1144 Exhibit: Etienne et al, 12 J Clinical Oncology 2248 1994
Document
IPR2019-00170, No. 1144-202 Exhibit - Etienne et al, 12 J Clinical Oncology 2248 1994 (P.T.A.B. Dec. 12, 2019)
|
|
Cite Document
2031 Exhibit: Gleevec¿¿ Label, downloaded from httpswwwaccessdatafdagovscript...
Document
IPR2019-00170, No. 2031-134 Exhibit - Gleevec¿¿ Label, downloaded from httpswwwaccessdatafdagovscriptscderdafindexcfmeventoverviewprocessApplNo021335 on August 19, 2019, 22 pag...
|
|
Cite Document
2023 Exhibit: Sorlie, et al, ¿¿¿Repeated Observation of Breast Tumor Subtypes in In...
Document
IPR2019-00170, No. 2023-126 Exhibit - Sorlie, et al, ¿¿¿Repeated Observation of Breast Tumor Subtypes in Independent Gene Expression Sets,¿¿¿ PNAS Vol 100, No 14, July 8, 2003, pp 8418 84...
|
|
Cite Document
2029 Exhibit: Leslie A Pray, ¿¿¿Gleevec¿¿ The Breakthrough in Cancer Treatment,¿¿¿...
Document
IPR2019-00170, No. 2029-132 Exhibit - Leslie A Pray, ¿¿¿Gleevec¿¿ The Breakthrough in Cancer Treatment,¿¿¿ Nature Education, Vol 1, 2008, 4 pages (P.T.A.B. Sep. 19, 2019)
|
|
Cite Document
2027 Exhibit: Lawrence et al, ¿¿¿Phase I Clinical Trial of Alitretinoin and Tamoxifen in...
Document
IPR2019-00170, No. 2027-130 Exhibit - Lawrence et al, ¿¿¿Phase I Clinical Trial of Alitretinoin and Tamoxifen in Breast Cancer Patients Toxicity, Pharmacokinetic, and Biomarker Evaluations,¿¿¿ J...
|
|
Cite Document
2050 Exhibit: Staker et al, ¿¿¿The Mechanism of Topoisomerase I Poisoning By a Ca...
Document
IPR2019-00170, No. 2050-153 Exhibit - Staker et al, ¿¿¿The Mechanism of Topoisomerase I Poisoning By a Camptothecin Analog,¿¿¿ PNAS, Vol 99, No 24, November 26, 2002, pp 15387 15392 (P...
|
|
Cite Document
1029 Exhibit: Thomas Jarvie, Next generation sequencing technologies, 2 Drug Dis...
Document
IPR2019-00170, No. 1029-21 Exhibit - Thomas Jarvie, Next generation sequencing technologies, 2 Drug Discovery Today Technologies 255 2005 (P.T.A.B. Nov. 5, 2018)
|
|
Cite Document
1045 Exhibit: HUGO Gene Nomenclature Committee Symbol Report ERBB2, availa...
Document
IPR2019-00170, No. 1045-37 Exhibit - HUGO Gene Nomenclature Committee Symbol Report ERBB2, available at httpswwwgenenamesorgcgi bingene symbol reporthgnc idHGNC3430 (P.T.A.B...
|
|
Cite Document
1002 Exhibit: Declaration of Paul T Spellman, PhD
Document
IPR2019-00170, No. 1002-77 Exhibit - Declaration of Paul T Spellman, PhD (P.T.A.B. Nov. 5, 2018)
|
|
Cite Document
1001 Exhibit: US Patent No9,372,193 the193 patent
Document
IPR2019-00170, No. 1001-58 Exhibit - US Patent No9,372,193 the193 patent (P.T.A.B. Nov. 5, 2018)
|
|
Cite Document
1065 Exhibit: Complaint
Document
IPR2019-00170, No. 1065-57 Exhibit - Complaint (P.T.A.B. Nov. 5, 2018)
|
|
Cite Document
1007 Exhibit: Amy L McDoniels Silvers et al, Differential Expression of Critical Cellu...
Document
IPR2019-00170, No. 1007-63 Exhibit - Amy L McDoniels Silvers et al, Differential Expression of Critical Cellular Genes in Human Lung Adenocarcinomas and Squamous Cell Carcinomas in Comp...
|
|
Cite Document
1061 Exhibit: NIH National Cancer Institute, How Imatinib Transformed Leukemia T...
Document
IPR2019-00170, No. 1061-53 Exhibit - NIH National Cancer Institute, How Imatinib Transformed Leukemia Treatment and Cancer Research, updated Apr 11, 2018 httpswwwcancergovresearchp...
|
|
Cite Document
1012 Exhibit: Jackson B Gibbs, Anticancer drug targets growth factors and growth ...
Document
IPR2019-00170, No. 1012-5 Exhibit - Jackson B Gibbs, Anticancer drug targets growth factors and growth factor signaling, 105 J Clinical Investigation 9 2000 (P.T.A.B. Nov. 5, 2018)
|
|
Cite Document
2071 Exhibit: Declaration of Jonathan Singer
Document
IPR2019-00170, No. 2071-174 Exhibit - Declaration of Jonathan Singer (P.T.A.B. Dec. 5, 2019)
|
|
Cite Document
